Vivace Therapeutics Funding: $105M Raised, Series D (2025)
Vivace Therapeutics is based in San Francisco Bay Area. It has raised $105M in total funding. Latest round: Series D.
Vivace Therapeutics funding overview
Vivace Therapeutics is based in San Francisco Bay Area. Vivace Therapeutics has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in February 2025. The round record for Vivace Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include RA Capital Management, Cenova Capital, Canaan Partners, WuXi Healthcare Ventures, Sequoia Capital China, Boxer Capital. 6 distinct backers are named across the disclosed rounds.
Vivace Therapeutics at a glance
Total raised
$105M
Latest round
Series D
Latest round date
February 2025
Headquarters
San Francisco Bay Area
Notable investors
RA Capital Management, Cenova Capital, Canaan Partners, WuXi Healthcare Ventures, Sequoia Capital China, Boxer Capital
Frequently asked about Vivace Therapeutics funding
How much has Vivace Therapeutics raised?
Vivace Therapeutics has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Vivace Therapeutics?
RA Capital Management, Cenova Capital, Canaan Partners, WuXi Healthcare Ventures, Sequoia Capital China, Boxer Capital are named among the investors backing Vivace Therapeutics.
What was the latest Vivace Therapeutics funding round?
The most recent disclosed round is a Series D, announced in February 2025.
Where is Vivace Therapeutics based?
Vivace Therapeutics is based in San Francisco Bay Area.
When did Vivace Therapeutics last raise?
The last disclosed Vivace Therapeutics round closed in February 2025 at Series D.
Round data for Vivace Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco Bay Area and backer lists below.
